CA-INGRAM-MICRO
INGRAM MICRO CLOUD SUMMIT – Ingram Micro Inc. today announced the next iteration of the Ingram Micro Cloud Marketplace, adding new features, functionality and resources designed to help technology partners and independent software vendors (ISVs) to do more with more. Inspired by partner feedback, the new enhancements streamline and standardize processes, increase efficiencies and effectiveness in sales and marketing, and ultimately will make it easier for technology partners and ISVs to grow their business more profitably using the Ingram Micro Cloud Marketplace.
Among the key enhancements and features readily available today as part of the Ingram Micro Cloud Marketplace are:
Ingram Micro Connect – Powered by CloudBlue, Ingram Micro Connect is an easy-to-use, digital module that provides a fast and cost-effective way to publish, manage and promote cloud services to as many as 200,000 technology partners using Ingram Micro Cloud Marketplace. Ingram Micro Connect simplifies and automates distribution by providing robust publishing tools, digital contracting, multi-marketplace targeting, and sales and marketing content creation tools.
New Customer Experience – A new, modern UI for the Ingram Micro Cloud Marketplace featuring an updated, user-friendly interface that makes it easier for technology partners to find, navigate, and purchase cloud services while streamlining end-customer management.
Sales & Marketing Hub – An industry-first, digital suite for technology partners designed to help educate and enable their salespeople on cloud services while providing pre-built campaign templates and valuable marketing tools to their marketers. The complementary resource provides a single destination to discover and learn about cloud services, create and execute marketing campaigns, and customize sales enablement and access industry insights so they can be the go-to cloud experts for their customers.
Marketplace API – A new API that enables technology partners to quickly integrate their own online storefront, CRM and billing systems into the Ingram Micro Cloud Marketplace. As a result, technology partners using the Cloud Marketplace can now better manage and automate ordering and billing; create and manage customer accounts, users and subscriptions; and retrieve billing data that can be used to bill end customers.
“Ingram Micro has elevated the experience our technology partners and ISVs are having with the Ingram Micro Cloud Marketplace, enabling them simply to do more with more and capitalize on the growing opportunity cloud continues to deliver,” said Tarik Faouzi, Vice President of Cloud Product Management, Ingram Micro. “These enhancements, powered by CloudBlue, all tie to Ingram Micro’s overall vision to provide our partners a hyper-scale digital platform, access to an infinite ecosystem, and proven go-to-market services.”
Ingram Micro’s Cloud Marketplace was first to market in 2009, and is now used by more than 55,000 technology partners worldwide to manage nearly four million fully-automated seats. The Ingram Micro Cloud Marketplace can be found here .
Supporting Partner Quotes and Industry Statistics
“Using Ingram Micro Connect, we’re able to quickly add our cloud
products to the Cloud Marketplace and position them in front of Ingram
Micro’s thousands of resellers with uniform, ready-to-use sales and
marketing resources.”
- Dmitry Leonov, Co-Founder, SaneBox
Channel partners spend up to 40 percent of their time sifting through
content.
- Source: Quotient, “Five Step Guide to Enable Channel
Sale,” May 2016
When enabled, resellers achieve 28 percent shorter sales cycles and a 12
percent higher lead conversion rate.
- Source: Aberdeen Group,
“Territory, Training, Technology: Best-in-Class Channel Sales
Management,” March 2016
A recent study from The 2112 Group notes 73% of MSPs don’t have
marketing plans or programs; 52% of partners say they’re expanding sales
and marketing efforts of existing products and services to grow their
business in 2019.
- Source: The 2112 Group, “2017 State of the
U.S. Cloud Channel Report”
“The Sales & Marketing Hub helps significantly reduce the time it takes
us to learn about vendor products and create the sales and marketing
assets that go along with them. Plus, we now have access to a library of
research on cloud business strategies and industry news that will help
us develop more effective strategies for our cloud business. GetBEE
looks forward to growing on the Sales & Marketing Hub with Ingram Micro.”
-
Thea Myhrvold, Founder and CEO, GetBEE
“Together, these new additions to the Cloud Marketplace will enable our
technology vendor partners to automate more processes and, as a result,
not only operate more efficiently to increase profits, but also to
expand their market footprint, and enable our reseller partners to
monetize an ever larger pool of anything as a service.”
- David
Wippich, CTO and Senior Vice President, Global Cloud, Ingram Micro
About Ingram Micro Cloud
At Ingram Micro Cloud,™ we view cloud not just as a single technology, but as a foundational platform to run and drive a whole new way of doing business. By leveraging our platforms and ecosystem, cloud service providers, telecom companies, resellers and enterprises can quickly transform and get up and running in the cloud within minutes, with little to no investment. Our portfolio includes vetted security, communication and collaboration, business applications, cloud management services and infrastructure solutions designed to help clients monetize and manage the entire lifecycle of cloud and digital services, infrastructure and IoT subscriptions. For more information, please visit: www.IngramMicroCloud.com .
About Ingram Micro Inc.
Ingram Micro helps businesses Realize the Promise of Technology ™. It delivers a full spectrum of global technology and supply chain services to businesses around the world. Deep expertise in technology solutions, mobility, cloud, and supply chain solutions enables its business partners to operate efficiently and successfully in the markets they serve. Unrivaled agility, deep market insights and the trust and dependability that come from decades of proven relationships, set Ingram Micro apart and ahead. More at www.ingrammicro.com .
View source version on businesswire.com: https://www.businesswire.com/news/home/20190313005555/en/
Contact:
Global Media Contact: Marie Rourke WhiteFox Marketing Inc. (for CloudBlue and Ingram Micro) 714-292-2199 marie@whitefoxpr.com
Social Media:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Axelspace: Notice of Signing a Service contract for In-Orbit Demonstration with Pale Blue, Inc.22.12.2025 10:00:00 CET | Press release
Axelspace Corporation (“Axelspace”), a leading microsatellite company committed to making “Space within Your Reach,” has entered into a service agreement with Pale Blue Inc. (“Pale Blue”), a company that develops, manufactures, and sells thrusters (engines) for small satellites, for an in-orbit demonstration, as detailed below. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251219321165/en/ Jun Asakawa, Co-founder & CEO of Pale Blue (left in photo) and Yuya Nakamura, President and CEO of Axelspace Axelspace provides AxelLiner Laboratory (AL Lab), a new service originating from the AxelLiner business that is specialized in in-orbit demonstration of space components. Under this contract, an in-orbit demonstration of a fast-start Hall thruster developed by Pale Blue is scheduled to be conducted in 2027. Nonetheless, conducting in-orbit demonstrations in a short period of time is known to be a significant challenge due to the in
Axelspace Signing Agreement on a Multi-Launch Arrangement and the Launch of New Satellites with Exolaunch22.12.2025 10:00:00 CET | Press release
Axelspace Corporation (“Axelspace”), a leading microsatellite company committed to making “Space within Your Reach,” is pleased to announce a multi-launch agreement (MLA) with Exolaunch, a global launch integrator and leader in launch mission management, satellite integration and satellite deployment technologies. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251219038364/en/ The Multi-Launch Agreement will accelerate the growth of Axelspace. In particular, one satellite scheduled for launch under the new Agreement will be used in the AxelLiner business’s in-orbit demonstration service, “AxelLiner Laboratory”. Exolaunch has already secured launches for eight (8) Axelspace’s satellites on the upcoming missions. Axelspace provides AxelLiner Laboratory (AL Lab), a new service originating from the AxelLiner business that is specialized in in-orbit demonstration of space components. Nonetheless, conducting in-orbit demonstration
Zambon Biotech Announces First Patient Dosed in Phase 3b ADIP Clinical Study of IPX203 in Parkinson’s Disease22.12.2025 10:00:00 CET | Press release
Zambon Biotech, a specialized biotech company part of the Zambon group that aims to build a scientifically robust and commercially viable portfolio of innovative patient-oriented drugs through the scouting, acquisition, licensing and development of new molecules, today announced that the first participant with advanced Parkinson’s disease has been enrolled in the European Phase 3b ADIP (IPX203 in Advanced Parkinson’s disease) study, which is planned to evaluate the efficacy and safety of IPX203 versus immediate-release (IR) levodopa/carbidopa (LD/CD) in a regimen which has not yet been the focus of a Phase 3 trial. IPX203 is a novel, oral modified-release formulation of LD/CD designed for the treatment of Parkinson’s disease, the fastest growing neurological condition in the world according to the World Health Organization1. IPX203 contains immediate-release granules and extended-release beads, providing both a rapid onset of action and a longer duration of benefit, sustaining the levo
Pimicotinib Approved as Systemic Treatment in China for Tenosynovial Giant Cell Tumor22.12.2025 09:00:00 CET | Press release
First regulatory approval in the world for pimicotinib based on positive data from global Phase 3 MANEUVER studyIn MANEUVER, pimicotinib significantly improved objective response rate at week 25 (54% vs. 3.2% for placebo), while providing clinically meaningful and statistically significant improvements across all patient-reported outcomesWith longer-term follow-up, 3 out of 4 patients treated with pimicotinib achieved response per RECIST v1.1, and treatment continued to be well-toleratedApproval strengthens Merck’s leadership in rare tumors, with additional ongoing regulatory filings for pimicotinib underway globally Merck, a leading science and technology company, announced today that following Priority Review, the China National Medical Products Administration (NMPA) has approved pimicotinib for the treatment of adult patients with symptomatic tenosynovial giant cell tumor (TGCT) for which surgical resection will potentially cause functional limitation or relatively severe morbidity.
Incyte Japan Announces Approval of Minjuvi® (tafasitamab) in Combination with Rituximab and Lenalidomide for the Treatment of Relapsed or Refractory Follicular Lymphoma22.12.2025 08:44:00 CET | Press release
Incyte Biosciences Japan G.K. today announced approval from Japan's Ministry of Health, Labour and Welfare (MHLW) for Minjuvi® (tafasitamab) in combination with rituximab and lenalidomide for adult patients with relapsed or refractory follicular lymphoma (2L+ FL). “Today's approval of Minjuvi in combination with rituximab and lenalidomide marks a significant milestone as the first dual-targeted CD19 and CD20 immunotherapy combination for relapsed or refractory FL in Japan,” said Yasuyuki Ishida, General Manager, Incyte Biosciences Japan. “By improving progression-free survival, Minjuvi offers a chemotherapy-free option for eligible patients with relapsed or refractory disease. This approval underscores our commitment to bridging critical treatment gaps to patients and families affected by this challenging disease in Japan.” The approval is based on the pivotal Phase 3 inMIND trial, which enrolled 654 adult patients, including patients based in Japan. The study demonstrated that Minjuvi
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom